Uncategorized

Embla Medical hf: Interim Report Q3 2025

PR Newswire
By PR Newswire
1 Min Read
Fallback image

COPENHAGEN, Denmark, Oct. 21, 2025 /PRNewswire/ — Announcement no. 49/2025 Interim report Q3 2025 21 October 2025 Sveinn Sölvason, President and CEO, comments: “Sales in Q3 2025 amounted to USD 237 million, representing 11% reported growth, of which 7% was organic. Growth picked up in…

​COPENHAGEN, Denmark, Oct. 21, 2025 /PRNewswire/ — Announcement no. 49/2025 Interim report Q3 2025 21 October 2025 Sveinn Sölvason, President and CEO, comments: “Sales in Q3 2025 amounted to USD 237 million, representing 11% reported growth, of which 7% was organic. Growth picked up in…  ​All Consumer Technology

Share This Article
ByPR Newswire
PR Newswire is the storytelling engine behind thousands of corporate announcements worldwide. With a rich legacy in media distribution, it helps brands turn their updates into meaningful narratives by connecting them with journalists, investors, and audiences who shape global conversations. Through trusted networks and data-backed distribution, PR Newswire ensures every story reaches the people who matter most.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *